Article Text
Commentary
Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?
Statistics from Altmetric.com
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.